Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Nick Reynolds

Newcastle AuthorsTitleYearFull text
Professor Nick Reynolds
A randomised placebo controlled trial of anakinra for treating pustular psoriasis: Statistical analysis plan for stage two of the APRICOT trial2020
Professor Nick Reynolds
Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)2020
Dr Nina Wilson
Professor Nick Reynolds
Dr Deborah Stocken
Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)2020
Dr Shyamal Wahie
Professor Nick Reynolds
Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study2020
Professor Nick Reynolds
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis2019
Dr Nina Wilson
Professor Nick Reynolds
Association of Serum Ustekinumab Levels with Clinical Response in Psoriasis2019
Professor Nick Reynolds
Clinical and genetic differences between pustular psoriasis subtypes2019
Dr Nina Wilson
Professor Nick Reynolds
Defining the therapeutic range for adalimumab and predicting response in psoriasis: amulticenter prospective observational cohort study2019
Dr Robert Ellis
Dr Diana Tang
Dr Batoul Nasr
Alison Greenwood
Dr Ashleigh McConnell
et al.
Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas2019
Professor Nick Reynolds
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study2019
1234567891011121314151617181920